Launching the "2026 World Class Offers"HONG KONG, June 4, 2026 /PRNewswire/ -- The quadrennial global football event is about to get the whole world...
Winners will receive a trip of a lifetime to visit the national park of their choice.WASHINGTON, June 1, 2026 /PRNewswire/ -- The National Park Foundation...
Launched as part of UO Haul: Special Delivery, the Dream Dorm Makeover Contest in collaboration with HGTV headlines the second phase of Urban Outfitters'...
Munich, Germany, July 04, 2025 – The Strüngmann Award selection committee today announced that Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D., the founders of Araris Biotech, have been honored as this year’s winners. The award aims to support outstanding entrepreneurial and scientific achievements, as well as ground-breaking ideas in the life sciences industry. Araris Biotech’s founding team distinguished itself not only by developing of a novel technology in the antibody-drug conjugates (ADCs) field, but also by successfully validating this innovation through partnerships and a preclinical exit. This new drug class has the potential to significantly advance the development of targeted cancer therapies, thereby delivering added value for people living with cancer worldwide.
FORT WORTH, Texas, July 3, 2025 /PRNewswire/ -- Four years since launching its first ever pitch competition, the eosera® Foundation is preparing to open...